TBMED aims to support med-tech companies in the development of high-risk medical devices by reducing their time-to-market for the European sector.

TBMED will help European SMEs to maintain their competitiveness and innovation capacity in the face of global competition, e.g. from larger providers. Its aim is to minimize time-to-market and efforts for reimbursement and make medical devices accessible to patients more easily.

Upcoming events

iSRS 2022

May 29, 2022 — June 02, 2022
Nantes, France

Magnetic Carrier Meeting 2022

June 14, 2022 — June 17, 2022
London, UK

IndTech 2022

June 28, 2022 — June 30, 2022
Grenoble, France

Facts and Figures

4 years
Duration

4 years

4 Countries
13 Partners

4 Countries

8.5 M €
Funding

8.5 M €

Consortium